跳至主要内容
临床试验/NCT02335073
NCT02335073已完成不适用

Effect of 4 Liver Fibrosis Tests (PIIINP, CIV, LN, and HA) on the Prognosis of Liver Cirrhosis: A Single-center, Prospective, Observational Study

General Hospital of Shenyang Military Region1 个研究点 分布在 1 个国家目标入组 108 人开始时间: 2015年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
108
试验地点
1
主要终点
Death

研究概览

简要总结

Liver biopsy is the reference method for the measurement of liver fibrosis. But it has many limitations, such as sampling error and individual variation in interpreting the results. Currently, serum liver fibrosis markers have been employed as non-invasive diagnosis of liver fibrosis and evaluation of the severity of liver fibrosis. They include laminin (LN), hyaluronic acid (HA), collagen type IV (CIV), and N-terminal propeptide of collagen III (PIIINP). However, few study was conducted to explore the role of these liver fibrosis markers in evaluating the prognosis of liver cirrhosis. Our hypothesis is that LN, HA, CIV, and PIIINP in combination or alone can predict the prognosis of liver cirrhosis.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Patients were admitted to our department.
  • Patients were diagnosed with liver cirrhosis.
  • Patients signed the informed consent and agreed to test serum liver fibrosis markers (PIIINP, CIV, LN, and HA).

排除标准

  • Non-cirrhotic patients.
  • Malignancy.
  • Severe cardiopulmonary diseases.
  • Severe infectious diseases.
  • Other diseases with a shortened lifespan.
  • Pregnant and breastfeeding.
  • Poor adherence.

结局指标

主要结局

Death

时间窗: 6-12 months

次要结局

  • Hepatic decompensation events(6-12 months)

研究者

发起方
General Hospital of Shenyang Military Region
申办方类型
Other
责任方
Principal Investigator
主要研究者

Xingshun Qi

Dr.

General Hospital of Shenyang Military Region

研究点 (1)

Loading locations...

相似试验